Nu Skin Enterprises Inc. Financials
NUS
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $1,322 | $1,485 | $1,732 | $1,969 | $2,226 | $2,696 |
| Cost of Revenue | $425 | $454 | $550 | $612 | $631 | $675 |
| Gross Profit | $897 | $1,031 | $1,182 | $1,357 | $1,595 | $2,020 |
| Operating Expenses | ||||||
| Selling & Marketing | $453 | $508 | $652 | $742 | $880 | $1,080 |
| General & Administrative | $391 | $432 | $479 | $547 | $556 | $654 |
| Research & Development | – | $11 | $13 | $23 | $23 | $27 |
| Total Operating Expenses | $924 | $966 | $1,333 | $1,309 | $1,484 | $1,786 |
| Operating Income | -$27 | $66 | -$152 | $48 | $111 | $234 |
| Non-Operating | ||||||
| Net Interest Expense | -$15 | -$14 | -$26 | -$26 | -$14 | -$11 |
| Other Non-Operating Income (Expense) | $2 | $144 | $3 | $4 | -$8 | $9 |
| EBT (Earnings Before Tax) | -$40 | $196 | -$175 | $27 | $89 | $232 |
| Income Tax Expense | $194 | $36 | -$28 | $18 | -$16 | $85 |
| Net Income | ||||||
| Net Income | -$234 | $160 | -$147 | $9 | $105 | $147 |
| Per Share Data | ||||||
| Revenue Per Share | $27.16 | $29.53 | $34.88 | $39.49 | $44.05 | $52.42 |
| EPS (Basic) | -$4.81 | $3.25 | -$2.95 | $0.17 | $2.10 | $2.93 |
| EPS (Diluted) | -$4.85 | $3.18 | -$2.95 | $0.17 | $2.07 | $2.86 |
| Weighted Avg Shares (Basic) | 48.7M | 49.3M | 49.7M | 49.7M | 50.0M | 50.2M |
| Weighted Avg Shares (Diluted) | 48.7M | 50.3M | 49.7M | 49.9M | 50.5M | 51.4M |
| Shares Outstanding | 48.7M | 50.3M | 49.7M | 49.9M | 50.5M | 51.4M |
| Dividends Per Share | $0.24 | $0.24 | $0.24 | $1.56 | $1.52 | $1.48 |
Nu Skin Enterprises (NUS) financials: revenue, profit and margins
Nu Skin Enterprises (NUS) generated about $1.3 billion in revenue and -$234 million in net income (a -17.7% net margin) over the trailing twelve months, growing at roughly -10.5% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is Nu Skin Enterprises's (NUS) revenue?+
Nu Skin Enterprises generated about $1.3 billion in revenue over the trailing twelve months. Revenue has grown at roughly -10.5% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Nu Skin Enterprises profitable?+
Nu Skin Enterprises reported about -$234 million in net loss over the trailing twelve months, a net margin of roughly -17.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Nu Skin Enterprises's profit margins?+
Nu Skin Enterprises runs a gross margin of about 67.8%, an operating margin of about -2.0%, a net margin of about -17.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Nu Skin Enterprises growing?+
Nu Skin Enterprises's revenue has compounded at roughly -10.5% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside NUS's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 31 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.
Fiscal year ends Dec.
Peers
Wholesale-Drugs, Proprietaries & Druggists' Sundries · Pick stocks to compare with NUS
Held by ETFs
NUS is in 29 US ETFs. The largest of them, with NUS's weight in each:
Avantis U.S. Small Cap Value ETFAVUV0.04%of the fund
iShares Russell 2000 Value ETFIWN0.02%of the fund
Dimensional U.S. Targeted Value ETFDFAT0.00%of the fund
Invesco RAFI US 1000 ETFPRF0.00%of the fund
Vanguard Consumer Staples ETFVDC0.03%of the fund
Schwab Fundamental U.S. Small Company ETFFNDA0.03%of the fund
Spot a number that looks wrong? Check it in NUS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NUS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.